Cover Image

Generic drug entry prior to patent expiration an FTC study /

Main Author:	United States. Federal Trade Commission.
Format:	Electronic
Language:	English
Published:	[Washington, D.C.] : The Commission, [2002]
Subjects:	Drugs -- United States -- Patents. Generic drugs -- United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS21619

Similar Items

Authorized generic drugs short-term effects and long-term impact
by: United States. Federal Trade Commission.
Published: (2011)

To promote innovation the proper balance of competition and patent law and policy : a report by the Federal Trade Commission
by: United States. Federal Trade Commission.
Published: (2003)

The evolving IP marketplace aligning patent notice and remedies with competition
by: United States. Federal Trade Commission.
Published: (2011)

Annual highlights ... : FTC highlights
by: United States. Federal Trade Commission,
Published: (2013)

Fulfilling the original vision the FTC at 90
by: United States. Federal Trade Commission.

A positive agenda for consumers the FTC year in review
by: United States. Federal Trade Commission.

Building a strong foundation the FTC year in review
by: United States. Federal Trade Commission.

Entry threats and pricing in the generic drug industry
by: Wendling, Brett.
Published: (2010)

Generic drug industry dynamics
by: Reiffen, David A.
Published: (2002)

Examining issues related to competition in the pharmaceutical marketplace : a review of the FTC report, generic drug entry prior to patent expiration : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, June 13 and October 10, 2002
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health,
Published: (2002)

Pay to delay are patent settlements that delay generic drug market entry anticompetitive? : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, June 3, 2009
by: United States. Congress. House. Committee on the Judiciary. Subcommittee on Courts and Competition Policy.
Published: (2010)

Protecting Consumer Access to Generic Drugs Act of 2007 hearing before the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, on H.R. 1902, May 2, 2007
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Commerce, Trade, and Consumer Protection.
Published: (2007)

H.R. 1706, the Protecting Consumer Access to Generic Drugs Act of 2009 hearing before the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, March 31 2009
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Commerce, Trade, and Consumer Protection.
Published: (2012)

FTC competition enforcement database
by: United States. Federal Trade Commission,
Published: (2009)

FTC policy statement on deception
by: United States. Federal Trade Commission.
Published: (1983)

FTC policy statement on unfairness
by: United States. Federal Trade Commission.
Published: (1980)

Generic drugs saving money at the pharmacy
Published: (1998)

Authorized generics : an interim report
Published: (2009)

Overview of FTC actions in pharmaceutical products and distribution
by: United States. Federal Trade Commission,

Overview of FTC antitrust actions in pharmaceutical services and products
by: United States. Federal Trade Commission,

Protecting Consumer Access to Generic Drugs Act of 2019 : report (to accompany H.R. 1499) (including cost estimate of the Congressional Budget Office)
by: United States. Congress. House. Committee on Energy and Commerce,
Published: (2019)

FTC policy statement regarding advertising substantiation
by: United States. Federal Trade Commission.
Published: (1987)

Overview of FTC actions in health care services and products
by: United States. Federal Trade Commission,

Generic animal drugs hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, second session, on H.R. 5069 ... July 29, 1986
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.
Published: (1987)

Overview of FTC antitrust actions in health care services and products
by: United States. Federal Trade Commission,

Lopid Patent Term Restoration and Fairness Act of 1987 : hearing before the Subcommittee on Courts, Civil Liberties, and the Administration of Justice of the Committee on the Judiciary, House of Representatives, One Hundredth Congress, first session, October 8, 1987
by: United States. Congress. House. Committee on the Judiciary. Subcommittee on Courts, Civil Liberties, and the Administration of Justice.
Published: (1988)

The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period
by: Olson, Luke M.,
Published: (2013)

Annual performance report for fiscal year ... and annual performance plan for fiscal years .
by: United States. Federal Trade Commission,
Published: (2019)

Fiscal year ... performance report and annual performance plan for fiscal years .
by: United States. Federal Trade Commission,
Published: (2014)

The FTC's first five years protecting consumers online : a report from the Federal Trade Commission staff
by: United States. Federal Trade Commission.
Published: (1999)

Annual report of the Federal Trade Commission for the fiscal year ended .
by: United States. Federal Trade Commission.
Published: (1915)

Annual report of the Federal Trade Commission for the fiscal year ended .
by: United States. Federal Trade Commission,
Published: (1915)

Federal Trade Commission : protecting America's consumers
by: United States. Federal Trade Commission,
Published: (2016)

Agency financial report
by: United States. Federal Trade Commission,
Published: (2014)

Telephone directory
by: United States. Federal Trade Commission.
Published: (1981)

Annual report to Congress pursuant to section (815)a of the Fair Debt Collection Practices Act
by: United States. Federal Trade Commission.

Report to Congress under Section 319 of the Fair and Accurate Credit Transactions Act of 2003
by: United States. Federal Trade Commission.
Published: (2010)

Drug issues : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, October 1, 1987--Orphan Drug Amendments of 1987 (H.R. 3349), October 5, 1987--Generic Animal Drug and Patent Term Restoration Act (H.R. 3120), May 16, 1988--Consumer Product Safe Testing Act (H.R. 1635)
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.
Published: (1988)

The value of a second bite at the apple the effect of patent dispute settlements on entry and consumer welfare
by: Schrag, Joel.
Published: (2006)

Enforcement policy statement on food advertising
by: United States. Federal Trade Commission.
Published: (1994)

In Prospector

Similar Items

Authorized generic drugs short-term effects and long-term impact
by: United States. Federal Trade Commission.
Published: (2011)
To promote innovation the proper balance of competition and patent law and policy : a report by the Federal Trade Commission
by: United States. Federal Trade Commission.
Published: (2003)
The evolving IP marketplace aligning patent notice and remedies with competition
by: United States. Federal Trade Commission.
Published: (2011)
Annual highlights ... : FTC highlights
by: United States. Federal Trade Commission,
Published: (2013)
Fulfilling the original vision the FTC at 90
by: United States. Federal Trade Commission.